SCHEMBL6951286

SCHEMBL6951286

N#Cc1c(N2CCc3ccccc3CC2)nc(CC(N)=O)[nH]c1=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 1/20 0.40
ALDH1A1 P00352 7/20 0.38
MAPT P10636 3/20 0.38
POLB P06746 2/20 0.38
AKT1 P31749 7/20 0.38
KDM4E B2RXH2 5/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MEN1 O00255 2/20 0.38
HTT P42858 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 2/20 0.36
ATM Q13315 1/20 0.36
PKM P14618 1/20 0.36
ALOX15 P16050 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952723 0.86 PDE9A (0.44) PDE9AALDH1A1MAPTPOLBAKT1
SCHEMBL6945691 0.84 PDE9A (0.45) PDE9AALDH1A1MAPTPOLBKDM4E
SCHEMBL6945649 0.82 PDE9A (0.41) PDE9AALDH1A1MAPTPOLBKDM4E
SCHEMBL6951302 0.80 PDE9A (0.40) PDE9AALDH1A1MAPTPOLBKDM4E
SCHEMBL6948400 0.80 XDH (0.51) ALDH1A1MAPTPOLBKDM4EHPGD
SCHEMBL6949420 0.80 DAO (0.40) PDE9AALDH1A1MAPTPOLBKDM4E
SCHEMBL6952968 0.78 HTR1A (0.41) PDE9AALDH1A1MAPTPOLBKDM4E
SCHEMBL6949962 0.78 GAA (0.43) ALDH1A1MAPTPOLBKDM4EHPGD
SCHEMBL6955411 0.77 RXFP1 (0.54) ALDH1A1MAPTPOLBKDM4EHPGD
SCHEMBL6948423 0.76 ALDH1A1 (0.42) PDE9AALDH1A1MAPTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed